コンテンツメニュー

Kawai Motoharu

Affiliate Master Yamaguchi University

Publish Date (<span class="translation_missing" title="translation missing: en.view.asc">Asc</span>)
Neurology : official journal of the American Academy of Neurology Volume 78 Issue 10 pp. 762 - 764
published_at 2012-03-06
Creators : Omoto M. Suzuki S. Ikeuchi T. Ishihara T. Kobayashi T. Tsuboi Y. Ogasawara J. Koga M. Kawai M. Iwaki T. Kanda T. Publishers : American Academy of Neurology | Lippincott Williams & Wilkins
Muscle & nerve Volume 46 Issue 4 pp. 610 - 611
published_at 2012-10
Creators : Haruki Hiroyo Koga Michiaki Ogasawara Jun-ichi Omoto Masatoshi Kawai Motoharu Kanda Takashi Publishers : Houghton Mifflin Medical Publication | Wiley
Clinical & experimental neuroimmunology Volume 3 Issue 2 pp. 85 - 87
published_at 2012-05
Creators : Kawai Motoharu Shimizu Fumitaka Omoto Masatoshi Ogasawara Jun-Ichi Takahashi Toshiyuki Kanda Takashi Publishers : Wiley-Blackwell
Clinical neurology Volume 52 Issue 10 pp. 744 - 749
published_at 2012
Creators : Oishi Mariko Kawai Motoharu Ogasawara Jun-ichi Koga Michiaki Kanda Takashi Publishers : 日本神経学会
PLoS ONE Volume 9 Issue 3 pp. e92872 -
published_at 2014-03-31
Creators : Shimizu Fumitaka Tasaki Ayako Sano Yasuteru Ju Mihua Nishihara Hideaki Oishi Mariko Koga Michiaki Kawai Motoharu Kanda Takashi Publishers : Public Library of Science
山口医学 Volume 64 Issue 1 pp. 53 - 57
published_at 2015-02-01
A 36-year-old man diagnosed with Charcot-Marie-Tooth(CMT)disease type 1B was treated in the department of neurology of this hospital. Due to a liver injury(AST 237IU/ml, ALT 496IU/ml)which occurred in November 200X, he was introduced to our department. As a result of scrutiny, we diagnosed him with chronic hepatitis C genotype 2a(HCV-RNA 5.4logIU/ml).He will be admitted to the hospital for Interferon(IFN)therapy in April next year. Although the mechanism is unknown, there are a few reports of peripheral neuropathy related to IFN therapy. Therefore, IFN therapy is generally unfavorable for patients with neuromuscular disorders. There are several IFN preparations used in Japan. IFN alfa associated peripheral neuropathy appears less than 0.1-5% of the time. While there is no report of peripheral neuropathy related to IFN beta, we performed IFN beta and Rivabirin combination therapy with a severe follow-up by a neurologist. We could accomplish treatment without the exacerbation of neurologic symptoms. He achieved sustained viral response. When IFN therapy was provided for chronic hepatitis B or chronic hepatitis C complicated with peripheral neuropathy, there is some possibility of performing antiviral therapy safely by using IFN beta.
山口医学 Volume 41 Issue 3 pp. 221 - 225
published_at 1992-06
Creators : Nogaki Hiroshi Kakinuma Susumu Kawai Motoharu Matsumoto Kaori Ohba Yukio Katoh Masayuki tsuda Naomi Fukusako Toshihiro Murashige Takeyoshi Akidomi Nobuhito Publishers : 山口大学医学会
山口医学 Volume 45 Issue 1 pp. 91 - 102
published_at 1996-02
Creators : Kawai Motoharu Publishers : 山口大学医学会
山口医学 Volume 52 Issue 5 pp. 169 - 173
published_at 2003-10-31
Creators : Tada Yukiko Negoro Kiyoshi Ogasawara Jun-ichi Kawai Motoharu Morimatsu Mitsunori Publishers : 山口大学医学会